

<!-- Generated by DataTracks version 1.1.5 on 27-Mar-2014 [01:10:54] {PM} EST - www.datatracks.com -->
<schema targetNamespace="http://www.alcobra-pharma.com/20131231" elementFormDefault="qualified" xmlns:adhd="http://www.alcobra-pharma.com/20131231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.alcobra-pharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>101 - Document - Document And Entity Information</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>102 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <link:definition>103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ConsolidatedStatementsOfComprehensiveLoss" id="ConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>104 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/StatementsOfChangesInShareholdersEquityDeficiency" id="StatementsOfChangesInShareholdersEquityDeficiency">
        <link:definition>105 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS&#39; EQUITY (DEFICIENCY)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/StatementsOfChangesInShareholdersEquityDeficiencyParanthetical" id="StatementsOfChangesInShareholdersEquityDeficiencyParanthetical">
        <link:definition>106 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS&#39; EQUITY (DEFICIENCY) (Paranthetical)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/General" id="General">
        <link:definition>108 - Disclosure - GENERAL</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>109 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ReceivablesAndPrepaidExpenses" id="ReceivablesAndPrepaidExpenses">
        <link:definition>110 - Disclosure - RECEIVABLES AND PREPAID EXPENSES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
        <link:definition>111 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/AccruedExpensesAndOtherLiabilities" id="AccruedExpensesAndOtherLiabilities">
        <link:definition>112 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ConvertibleNotes" id="ConvertibleNotes">
        <link:definition>113 - Disclosure - CONVERTIBLE NOTES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>114 - Disclosure - INCOME TAXES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ContingentLiabilitiesAndCommitments" id="ContingentLiabilitiesAndCommitments">
        <link:definition>115 - Disclosure - CONTINGENT LIABILITIES AND COMMITMENTS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ShareholdersEquityDeficiency" id="ShareholdersEquityDeficiency">
        <link:definition>116 - Disclosure - SHAREHOLDERS&#39; EQUITY (DEFICIENCY)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/RelatedPartyBalancesAndTransactions" id="RelatedPartyBalancesAndTransactions">
        <link:definition>117 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/FinancialExpensesNet" id="FinancialExpensesNet">
        <link:definition>118 - Disclosure - FINANCIAL EXPENSES, NET</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/BasicAndDilutedNetLossPerShare" id="BasicAndDilutedNetLossPerShare">
        <link:definition>119 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>120 - Disclosure - SUBSEQUENT EVENTS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>121 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
        <link:definition>122 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ReceivablesAndPrepaidExpensesTables" id="ReceivablesAndPrepaidExpensesTables">
        <link:definition>123 - Disclosure - RECEIVABLES AND PREPAID EXPENSES (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
        <link:definition>124 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/AccruedExpensesAndOtherLiabilitiesTables" id="AccruedExpensesAndOtherLiabilitiesTables">
        <link:definition>125 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <link:definition>126 - Disclosure - INCOME TAXES (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ContingentLiabilitiesAndCommitmentsTables" id="ContingentLiabilitiesAndCommitmentsTables">
        <link:definition>127 - Disclosure - CONTINGENT LIABILITIES AND COMMITMENTS (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ShareholdersEquityDeficiencyTables" id="ShareholdersEquityDeficiencyTables">
        <link:definition>128 - Disclosure - SHAREHOLDERS&#39; EQUITY (DEFICIENCY) (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/RelatedPartyBalancesAndTransactionsTables" id="RelatedPartyBalancesAndTransactionsTables">
        <link:definition>129 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/FinancialExpensesNetTables" id="FinancialExpensesNetTables">
        <link:definition>130 - Disclosure - FINANCIAL EXPENSES, NET (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/BasicAndDilutedNetLossPerShareTables" id="BasicAndDilutedNetLossPerShareTables">
        <link:definition>131 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/GeneralDetailsTextual" id="GeneralDetailsTextual">
        <link:definition>132 - Disclosure - GENERAL (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/SignificantAccountingPoliciesDetails" id="SignificantAccountingPoliciesDetails">
        <link:definition>133 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/SignificantAccountingPoliciesDetailsTextual" id="SignificantAccountingPoliciesDetailsTextual">
        <link:definition>134 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ReceivablesAndPrepaidExpensesDetails" id="ReceivablesAndPrepaidExpensesDetails">
        <link:definition>135 - Disclosure - RECEIVABLES AND PREPAID EXPENSES (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
        <link:definition>136 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/PropertyAndEquipmentNetDetailsTextual" id="PropertyAndEquipmentNetDetailsTextual">
        <link:definition>137 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/AccruedExpensesAndOtherLiabilitiesDetails" id="AccruedExpensesAndOtherLiabilitiesDetails">
        <link:definition>138 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ConvertibleNotesDetailsTextual" id="ConvertibleNotesDetailsTextual">
        <link:definition>139 - Disclosure - CONVERTIBLE NOTES (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
        <link:definition>140 - Disclosure - INCOME TAXES (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
        <link:definition>141 - Disclosure - INCOME TAXES (Details 1)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/IncomeTaxesDetailsTextual" id="IncomeTaxesDetailsTextual">
        <link:definition>142 - Disclosure - INCOME TAXES (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ContingentLiabilitiesAndCommitmentsDetails" id="ContingentLiabilitiesAndCommitmentsDetails">
        <link:definition>143 - Disclosure - CONTINGENT LIABILITIES AND COMMITMENTS (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ContingentLiabilitiesAndCommitmentsDetailsTextual" id="ContingentLiabilitiesAndCommitmentsDetailsTextual">
        <link:definition>144 - Disclosure - CONTINGENT LIABILITIES AND COMMITMENTS (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ShareholdersEquityDeficiencyDetails" id="ShareholdersEquityDeficiencyDetails">
        <link:definition>145 - Disclosure - SHAREHOLDERS&#39; EQUITY (DEFICIENCY) (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ShareholdersEquityDeficiencyDetails1" id="ShareholdersEquityDeficiencyDetails1">
        <link:definition>146 - Disclosure - SHAREHOLDERS&#39; EQUITY (DEFICIENCY) (Details 1)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ShareholdersEquityDeficiencyDetails2" id="ShareholdersEquityDeficiencyDetails2">
        <link:definition>147 - Disclosure - SHAREHOLDERS&#39; EQUITY (DEFICIENCY) (Details 2)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ShareholdersEquityDeficiencyDetails3" id="ShareholdersEquityDeficiencyDetails3">
        <link:definition>148 - Disclosure - SHAREHOLDERS&#39; EQUITY (DEFICIENCY) (Details 3)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/ShareholdersEquityDeficiencyDetailsTextual" id="ShareholdersEquityDeficiencyDetailsTextual">
        <link:definition>149 - Disclosure - SHAREHOLDERS&#39; EQUITY (DEFICIENCY) (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/RelatedPartyBalancesAndTransactionsDetails" id="RelatedPartyBalancesAndTransactionsDetails">
        <link:definition>150 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/RelatedPartyBalancesAndTransactionsDetailsTextual" id="RelatedPartyBalancesAndTransactionsDetailsTextual">
        <link:definition>151 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/BasicAndDilutedNetLossPerShareDetails" id="BasicAndDilutedNetLossPerShareDetails">
        <link:definition>152 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/FinancialExpensesNetDetails" id="FinancialExpensesNetDetails">
        <link:definition>153 - Disclosure - FINANCIAL EXPENSES, NET (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.alcobra-pharma.com/role/SubsequentEventsDetailsTextual" id="SubsequentEventsDetailsTextual">
        <link:definition>154 - Disclosure - SUBSEQUENT EVENTS (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:linkbaseRef xlink:type="simple" xlink:href="adhd-20131231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="adhd-20131231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="adhd-20131231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="adhd-20131231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>

  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />

  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />

  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />

  <import namespace="http://fasb.org/us-gaap/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/currency/2012-01-31" schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/exch/2013-01-31" schemaLocation="http://xbrl.sec.gov/exch/2013/exch-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />

  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />

  <import namespace="http://xbrl.sec.gov/dei/2013-01-31" schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd" />

  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />

  <import namespace="http://fasb.org/us-types/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd" />

  <element name="ReceivablesAndPrepaidExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ReceivablesAndPrepaidExpensesAbstract" />

  <element name="ReceivablesAndPrepaidExpensesTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ReceivablesAndPrepaidExpensesTextBlock" />

  <element name="ReceivablesAndPrepaidExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="adhd_ReceivablesAndPrepaidExpenses" />

  <element name="FinancialStatementsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_FinancialStatementsPolicyTextBlock" />

  <element name="ShortTermDepositPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ShortTermDepositPolicyTextBlock" />

  <element name="LongTermDepositPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_LongTermDepositPolicyTextBlock" />

  <element name="SeverancePayPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_SeverancePayPolicyTextBlock" />

  <element name="PropertyAndEquipmentScheduleOfDepreciationRateTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_PropertyAndEquipmentScheduleOfDepreciationRateTableTextBlock" />

  <element name="ScheduleOfReceivablesAndPrepaidExpensesCurrentTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ScheduleOfReceivablesAndPrepaidExpensesCurrentTableTextBlock" />

  <element name="ScheduleOfRateOfCalculatingDepreciationForPropertyPlantAndEquipmentTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ScheduleOfRateOfCalculatingDepreciationForPropertyPlantAndEquipmentTableTextBlock" />

  <element name="ScheduleOfOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="adhd_ScheduleOfOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" />

  <element name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />

  <element name="ScheduleOfPropertyAndEquipmentScheduleOfDepreciationRateTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="adhd_ScheduleOfPropertyAndEquipmentScheduleOfDepreciationRateTable" />

  <element name="ClinicalAndMedicalEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ClinicalAndMedicalEquipmentMember" />

  <element name="PropertyAndEquipmentScheduleOfDepreciationRateLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_PropertyAndEquipmentScheduleOfDepreciationRateLineItems" />

  <element name="ScheduleOfAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="adhd_ScheduleOfAccountingPoliciesTable" />

  <element name="AccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_AccountingPoliciesLineItems" />

  <element name="ShortTermDepositWeightedAverageInterestRate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ShortTermDepositWeightedAverageInterestRate" />

  <element name="PercentageOfSeverancePay" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_PercentageOfSeverancePay" />

  <element name="ScheduleOfReceivablesAndPrepaidExpensesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="adhd_ScheduleOfReceivablesAndPrepaidExpensesTable" />

  <element name="ReceivablesAndPrepaidExpensesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ReceivablesAndPrepaidExpensesLineItems" />

  <element name="ScheduleOfRateOfCalculatingDepreciationForPropertyPlantAndEquipmentTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="adhd_ScheduleOfRateOfCalculatingDepreciationForPropertyPlantAndEquipmentTable" />

  <element name="RateOfCalculatingDepreciationForPropertyPlantAndEquipmentLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_RateOfCalculatingDepreciationForPropertyPlantAndEquipmentLineItems" />

  <element name="ScheduleOfAccountsPayableAndAccruedLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="adhd_ScheduleOfAccountsPayableAndAccruedLiabilitiesTable" />

  <element name="AccountsPayableAndAccruedLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_AccountsPayableAndAccruedLiabilitiesLineItems" />

  <element name="TaxExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_TaxExpenses" />

  <element name="DeemedDividend" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_DeemedDividend" />

  <element name="OperatingLeaseAgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="adhd_OperatingLeaseAgreementAxis" />

  <element name="OfficeOfChiefScientistMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_OfficeOfChiefScientistMember" />

  <element name="RoyaltiesPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="adhd_RoyaltiesPercentage" />

  <element name="DescriptionOfGrantReceived" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_DescriptionOfGrantReceived" />

  <element name="EmployeesAndDirectorsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_EmployeesAndDirectorsMember" />

  <element name="GrantedToConsultantsOnApril22008Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_GrantedToConsultantsOnApril22008Member" />

  <element name="GrantedToConsultantsOnFebruary282010Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_GrantedToConsultantsOnFebruary282010Member" />

  <element name="GrantedToConsultantsOnFebruary132011Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_GrantedToConsultantsOnFebruary132011Member" />

  <element name="GrantedToConsultantsOnFebruary172011Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_GrantedToConsultantsOnFebruary172011Member" />

  <element name="GrantedToConsultantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_GrantedToConsultantsMember" />

  <element name="Granted1ToUnderwritersOnMay282013Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_Granted1ToUnderwritersOnMay282013Member" />

  <element name="Granted2ToUnderwritersOnMay282013Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_Granted2ToUnderwritersOnMay282013Member" />

  <element name="Granted3ToUnderwritersOnMay282013Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_Granted3ToUnderwritersOnMay282013Member" />

  <element name="Granted3ToUnderwritersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_Granted3ToUnderwritersMember" />

  <element name="SecondaryPublicOfferingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_SecondaryPublicOfferingMember" />

  <element name="IncentiveOptionPlan2010Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_IncentiveOptionPlan2010Member" />

  <element name="RecognizedIn2014Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_RecognizedIn2014Member" />

  <element name="RecognizedIn2015Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_RecognizedIn2015Member" />

  <element name="NumberOfWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_NumberOfWarrantsExercised" />

  <element name="CommonSharesIssuedWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_CommonSharesIssuedWarrantsExercised" />

  <element name="RelatedPartyExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_RelatedPartyExpensesAbstract" />

  <element name="StockIssuedDuringPeriodValueIssuesOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodValueIssuesOne" />

  <element name="StockIssuedDuringPeriodSharesIssuesOne" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodSharesIssuesOne" />

  <element name="StockIssuedDuringPeriodValueIssuesTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodValueIssuesTwo" />

  <element name="StockIssuedDuringPeriodSharesIssuesTwo" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodSharesIssuesTwo" />

  <element name="IssuanceOfPreferredStockAndWarrantsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_IssuanceOfPreferredStockAndWarrantsValue" />

  <element name="IssuanceOfPreferredStockAndWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_IssuanceOfPreferredStockAndWarrantsShares" />

  <element name="StockIssuedDuringPeriodValuesConversionOfDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodValuesConversionOfDebt" />

  <element name="StockIssuedDuringPeriodSharesConversionOfDebt" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodSharesConversionOfDebt" />

  <element name="DeemedDividendOfEquityResructuring" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_DeemedDividendOfEquityResructuring" />

  <element name="StockIssuedDuringPeriodValueConversionOfLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodValueConversionOfLoan" />

  <element name="StockIssuedDuringPeriodSharesConversionOfLoan" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodSharesConversionOfLoan" />

  <element name="StockIssuedDuringPeriodValueExerciseOfCashlessWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodValueExerciseOfCashlessWarrants" />

  <element name="StockIssuedDuringPeriodSharesExerciseOfCashlessWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodSharesExerciseOfCashlessWarrants" />

  <element name="StockIssuedDuringPeriodValueNewIssuesOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodValueNewIssuesOne" />

  <element name="StockIssuedDuringPeriodSharesNewIssuesOne" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_StockIssuedDuringPeriodSharesNewIssuesOne" />

  <element name="ConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ConsultantMember" />

  <element name="PreClinicalClinicalRegulatoryAndIntellectualPropertyIssuesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_PreClinicalClinicalRegulatoryAndIntellectualPropertyIssuesMember" />

  <element name="ReceivablesAndPrepaidExpensesCurrentTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="adhd_ReceivablesAndPrepaidExpensesCurrentTable" />

  <element name="ReceivablesAndPrepaidExpensesCurrentLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ReceivablesAndPrepaidExpensesCurrentLineItems" />

  <element name="InterestExpenseExchangeRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="adhd_InterestExpenseExchangeRate" />

  <element name="BankFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="adhd_BankFees" />

  <element name="ConvertibleEquityIssuancePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ConvertibleEquityIssuancePricePerShare" />

  <element name="EquityIssuanceCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_EquityIssuanceCost" />

  <element name="IncreaseDecreaseInReceivablesAndPrepaidExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_IncreaseDecreaseInReceivablesAndPrepaidExpense" />

  <element name="InvestmentInProceedsFromRestrictedBankDeposit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_InvestmentInProceedsFromRestrictedBankDeposit" />

  <element name="IssuanceOfPreferredBSharesAndWarrantsUponConversionOfConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_IssuanceOfPreferredBSharesAndWarrantsUponConversionOfConvertibleNotes" />

  <element name="IssuanceOfOrdinarySharesUponConversionOfLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="adhd_IssuanceOfOrdinarySharesUponConversionOfLoans" />

  <element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_DocumentAndEntityInformationAbstract" />

  <element name="ReceivablesAndPrepaidExpensesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="adhd_ReceivablesAndPrepaidExpensesCurrent" />

  <element name="ScheduleOfComprehensiveIncomeLossTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="adhd_ScheduleOfComprehensiveIncomeLossTable" />

  <element name="ComprehensiveIncomeLossLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_ComprehensiveIncomeLossLineItems" />

  <element name="OperatingLeaseAgreementDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_OperatingLeaseAgreementDomain" />

  <element name="NewOperatingLeaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_NewOperatingLeaseAgreementMember" />

  <element name="December312014Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_December312014Member" />

  <element name="TwoEmployeesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="adhd_TwoEmployeesMember" />
</schema>






